EZM0414 is a potent and selective, orally bioavailable inhibitor of SETD2 with an IC50 of 18 nM in biochemical assays and 34 nM in cellular assays, potentially useful for researching relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma [1].
Molecular Weight:
400.49
Purity:
99.58%
CAS Number:
[2411748-50-8]
Formula:
C22H29FN4O2
Target:
Histone Methyltransferase
T9969
* VAT and and shipping costs not included. Errors and price changes excepted